A phase 1a/1b study to evaluate the safety, tolerability, pharmacokinetics, and anti-tumor activity of IMGS-001 in patients with relapsed or refractory advanced solid tumors.

Authors: David S. Hong, Shiraj Sen, Charles Schweizer, Amanda Sanders, Chelsey Grimes, Federica Pericle, Christine Gagliardi, James Barlow, Ahmed Salameh, Michael A. Curran

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps2686

Source: Full article

---

Abstract

TPS2686